Greenberg, R. G., Lang, J., Smith, P. B., Shekhawat, P., Courtney, S. E., Hudak, M. L., … Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee. (2025). Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629. J Pediatr, 285, 114734. https://doi.org/10.1016/j.jpeds.2025.114734

Greenberg, Rachel G., Jason Lang, P Brian Smith, Prem Shekhawat, Sherry E. Courtney, Mark L. Hudak, Fernando Moya, et al. “Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629.” J Pediatr 285 (October 2025): 114734. https://doi.org/10.1016/j.jpeds.2025.114734.

Greenberg RG, Lang J, Smith PB, Shekhawat P, Courtney SE, Hudak ML, et al. Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629. J Pediatr. 2025 Oct;285:114734.

Greenberg, Rachel G., et al. “Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629.” J Pediatr, vol. 285, Oct. 2025, p. 114734. Pubmed, doi:10.1016/j.jpeds.2025.114734.

Greenberg RG, Lang J, Smith PB, Shekhawat P, Courtney SE, Hudak ML, Moya F, Iyengar A, Eldemerdash A, Bloom B, Go M, Hanna M, Rhein L, Aliaga S, Lewis T, Febre A, Kiefer AS, Bhatt-Mehta V, Khoury JA, Selewski D, Anand R, Martz K, Payne EH, Zimmerman KO, Benjamin DK, Laughon M, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee. Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629. J Pediatr. 2025 Oct;285:114734.